Interestingly, migration assays showed that osteoblasttumor cultures exhibited increased motility, which could be reverted by MERTK blockade, indicating that tumor cells induce osteoblast motility which counteracts osteoblast bone-forming activity (SFig. 13b, h–j). The gene discussed is MERTK; the disease is neoplasm.